Skip to main content

Doo-San Baek

Seoul National University · Medicine

About the Lab

Professor Doo-San Baek's research lab specializes in the discovery and development of novel therapeutic antibodies and targeted biologics for cancer and inflammatory diseases. The lab focuses on engineering human antibody libraries, including Fab and VH domains, for high-affinity targeting of disease-relevant antigens such as SARS-CoV-2 spike protein, ADAM10, CEACAM5, and neutrophil elastase. Utilizing advanced techniques like phage display, yeast surface display, and recombinant protein expression, the lab develops therapeutic candidates with potent neutralizing or inhibitory activities, emphasizing translational applications in oncology and infectious diseases. The research integrates structural immunology, synthetic biology, and translational medicine to advance next-generation biologics.

antibody engineeringtherapeutic antibodiescancer immunotherapytargeted therapyphage display

Research Overview

Papers
33
Total Citations
359
Papers (5y)
8
Primary Field
Medicine

Research Output Trend

Figures are computed from collected data and may differ slightly.

Publications per year (5y)
8total
2022
2023
2024
2025
2026
Citations per year (5y)
72total
20222023202420252026

Selected Papers

15
1
Article|64 citations·2020
Potent neutralization of SARS-CoV-2 by human antibody heavy-chain variable domains isolated from a large library with a new stable scaffold
Zehua Sun, Chuan Chen, Wei Li, David R. Martinez, Aleksandra Drelich, Du-San Baek, Xianglei Liu, John W. Mellors, Chien‐Te K. Tseng, Ralph S. Baric, Dimiter S. Dimitrov
SJR Q1mAbsOA

Effective therapies are urgently needed for COVID-19. Here we describe the identification of a new stable human immunoglobulin G1 heavy-chain variable (VH) domain scaffold that was used for the construction of a large library, lCAT6, of engineered human VHs. This library was panned against the receptor-binding domain (RBD) of the SARS-CoV-2 spike (S) glycoprotein. Two VH domains (VH ab6 and VH m397) were selected and fused to Fc for increased half-life in circulation. The VH-Fc ab6 and m397 spec

Radiology, Nuclear Medicine and ImagingMedicine
2
Article|44 citations·2017
Production of recombinant human procollagen type I C-terminal propeptide and establishment of a sandwich ELISA for quantification
Woo‐Young Seo, Jeong‐Ho Kim, Du-San Baek, Su‐Jung Kim, Su‐Jin Kang, Won Suk Yang, Ji-Ae Song, Moo‐Seung Lee, Sung‐Hoon Kim, Yong‐Sung Kim, Sung‐Hoon Kim, Yong‐Sung Kim
SJR Q1Scientific ReportsOA

Procollagen type I carboxy-terminal propeptide (PICP), derived from type I procollagen, has been identified as an indicator of type I collagen synthesis in bone matrix formation and skin recovery. PICP is a heterotrimeric glycoprotein consisting of two α1 chains (PICPα1) and one α2 chain (PICPα2). Here, we report the recombinant expression of human PICP using a mammalian expression system. Co-expression of PICPα1 and PICPα2 in HEK293F cells resulted in the production of functional PICP in the co

OncologyMedicine
3
Article|34 citations·2014
Construction of a Large Synthetic Human Fab Antibody Library on Yeast Cell Surface by Optimized Yeast Mating
Du-San Baek, Yong‐Sung Kim
SJR Q2Journal of Microbiology and BiotechnologyOA

Yeast surface-displayed antibody libraries provide an efficient and quantitative screening resource for given antigens, but suffer from typically modest library sizes owing to low yeast transformation efficiency. Yeast mating is an attractive method for overcoming the limit of yeast transformation to construct a large, combinatorial antibody library, but the optimal conditions have not been reported. Here, we report a large synthetic human Fab (antigen binding fragment) yeast surface-displayed l

Radiology, Nuclear Medicine and ImagingMedicine
4
Article|33 citations·2021
A highly-specific fully-human antibody and CAR-T cells targeting CD66e/CEACAM5 are cytotoxic for CD66e-expressing cancer cells in vitro and in vivo
Du-San Baek, Ye‐Jin Kim, Sandra Vergara, Alex Conard, Cynthia Adams, Guillermo Calero, Rieko Ishima, John W. Mellors, Dimiter S. Dimitrov
SJR Q1Cancer Letters
OncologyMedicine
5
Article|33 citations·2019
Dual-targeting of EGFR and Neuropilin-1 attenuates resistance to EGFR-targeted antibody therapy in KRAS-mutant non-small cell lung cancer
Ye‐Jin Kim, Ye-Jin Kim, Du-San Baek, Seyoung Lee, Daechan Park, Han Na Kang, Byoung Chul Cho, Yong‐Sung Kim, Yong‐Sung Kim
SJR Q1Cancer LettersOA
Immunology and AllergyMedicine
6
Article|24 citations·2023
Fully human monoclonal antibody targeting activated ADAM10 on colorectal cancer cells
Nayanendu Saha, Du-San Baek, Rachelle Mendoza, Dorothea Robev, Yan Xu, Yehuda Goldgur, M. Jason de la Cruz, Elisa de Stanchina, Peter W. Janes, Kai Xu, Dimiter S. Dimitrov, Dimitar B. Nikolov
SJR Q1Biomedicine & PharmacotherapyOA

Metastasis and chemoresistance in colorectal cancer are mediated by certain poorly differentiated cancer cells, known as cancer stem cells, that are maintained by Notch downstream signaling initiated upon Notch cleavage by the metalloprotease ADAM10. It has been shown that ADAM10 overexpression correlates with aberrant signaling from Notch, erbBs, and other receptors, as well as a more aggressive metastatic phenotype, in a range of cancers including colon, gastric, prostate, breast, ovarian, ute

OncologyMedicine
7
Article|22 citations·2015
Humanization of a phosphothreonine peptide-specific chicken antibody by combinatorial library optimization of the phosphoepitope-binding motif
Du-San Baek, Yong‐Sung Kim
SJR Q2Biochemical and Biophysical Research Communications
Radiology, Nuclear Medicine and ImagingMedicine
8
Article|22 citations·2021
Human Antibody Domains and Fragments Targeting Neutrophil Elastase as Candidate Therapeutics for Cancer and Inflammation-Related Diseases
Xiaojie Chu, Zehua Sun, Du-San Baek, Wei Li, John W. Mellors, Steven D. Shapiro, Dimiter S. Dimitrov
SJR Q1International Journal of Molecular SciencesOA

Neutrophil elastase (NE) is a serine protease released during neutrophil maturation. High levels of NE are related to lung tissue damage and poor prognosis in cancer; thus, NE is a potential target for therapeutic immunotherapy for multiple lung diseases and cancers. Here, we isolate and characterize two high-affinity, specific, and noncompetitive anti-NE antibodies Fab 1C10 and VH 1D1.43 from two large phage-displayed human Fab and VH libraries. After fusion with human IgG1 Fc, both of them (VH

Immunology and AllergyMedicine
9
Article|22 citations·2023
Chimeric antigen receptor-T cells are effective against CEACAM5 expressing non-small cell lung cancer cells resistant to antibody-drug conjugates
Ye‐Jin Kim, Wei Li, Doncho V. Zhelev, John W. Mellors, Dimiter S. Dimitrov, Du-San Baek
SJR Q2Frontiers in OncologyOA

Chimeric antigen receptor-T (CAR-T) cells and antibody-drug conjugates (ADCs) are promising therapeutic strategies in oncology. The carcinoembryonic antigen-related cell adhesion molecule 5 (CEACAM5) is overexpressed in tumors including non-small cell lung cancer (NSCLC) and pancreatic ductal adenocarcinoma (PDAC), and is an attractive target for therapies based on CAR-T cell or/and ADCs. We previously developed a highly specific antibody-based CAR-T cells targeting CEACAM5 and the tumoricidal e

OncologyMedicine
10
Article|17 citations·2023
Human antibodies targeting ENPP1 as candidate therapeutics for cancers
Xiaojie Chu, Du-San Baek, Wei Li, Taras Shyp, Brian Mooney, Margaret G. Hines, Gregg B. Morin, Poul H. Sorensen, Dimiter S. Dimitrov
SJR Q1Frontiers in ImmunologyOA

Ectonucleotide pyrophosphatase/phosphodiesterase 1 (ENPP1) is a type II transmembrane glycoprotein expressed in many tissues. High expression levels of ENPP1 have been observed in many cancer types such as lung cancer, ovarian cancer, and breast cancer. Such overexpression has been associated with poor prognosis in these diseases. Hence, ENPP1 is a potential target for immunotherapy across multiple cancers. Here, we isolated and characterized two high-affinity and specific anti-ENPP1 Fab antibod

ImmunologyImmunology and Microbiology
11
Article|11 citations·2017
Immunoglobulin Fc-Fused Peptide without C-Terminal Arg or Lys Residue Augments Neuropilin-1-Dependent Tumor Vascular Permeability
Du-San Baek, Jeong‐Ho Kim, Ye‐Jin Kim, Yong‐Sung Kim, Yong‐Sung Kim, Yong‐Sung Kim
SJR Q1Molecular Pharmaceutics

Neuropilin-1 (NRP1), which functions as a coreceptor for vascular endothelial growth factor (VEGF) and is implicated in vascular permeability and tumorigenesis, has been targeted by peptides that specifically bind to the VEGF-binding region on NRP1. Like natural VEGF ligands, all known peptides with NRP1-binding activity bind only through a carboxy (C)-terminal R/K-x-x-R/K sequence motif (x stands for any amino acids); this strict requirement is called the C-end rule (CendR). Here, we report imm

Molecular BiologyBiochemistry, Genetics and Molecular Biology
12
Article|4 citations·2016
Content-based Configuration Management System for Software Research and Development Document Artifacts
Du-San Baek, Byungjeong Lee, Jungwon Lee
SJR Q3KSII Transactions on Internet and Information Systems

Because of the properties of software such as invisibility, complexity, and changeability, software configuration management (SCM) for software artifacts generated during software life-cycle has been used for guarantee of the quality of the software. However, the existing SCM system has only focused on code artifacts and software development document artifacts such as Software Requirements Specification (SRS), Software Design Description (SDD), and Software Test Description (STD). Moreover, soft

Artificial IntelligenceComputer Science
13
Article|4 citations·2018
An energy efficiency grading system for mobile applications based on usage patterns
Du-San Baek, Jae-Hyeon Park, Jungwon Lee
SJR Q2The Journal of Supercomputing
Electrical and Electronic EngineeringEngineering
14
Article|4 citations·2015
우전(雨田) 원세하(元世夏), 조선적 무대미술의 여정 - 원우전 무대미술 연구 시론
백두산
한국연극학

국문초록이 논문은 새로 발굴된 원우전(元雨田)(1895-1970)의 무대디자인과 생애자료를 중심으로 무대미술 활동의 의미를 규명하는 시론(試論)이다. 원우전의 본명은 원세하(元世夏)로, 서울에서 태어나 경신학교, 서화미술회에서 수학하고 <백조> 동인으로 활동하였다. 이 시절 홍사용 등의 회고에서 엿보이는 조선적인 것에 대한 관심과 낭만적 기질은 그의 예술을 관통하는 화두이다. 서양화가들이 주도하였던 토월회 1기 공연의 성과와 한계를 바탕삼아 원우전은 김운선, 미다라이(御手洗) 등의 무대장치가와 교류, 무대기술을 연구하였고, ‘전이모사’와 세밀화 기술 등 동양화 제작 방식을 무대미술 제작에 응용하였다. 2기 토월회 미술을 주도한 원우전은 입체무대와 배경막의 절충으로 당대 연극무대의 한계였던 일본 가부키식의 전형적 무대미술을 혁신했다. 1929년 토월회 <아리랑 고개> 무대의 핵심인 ‘길’은 배경막과 입체무대를 절충하여 긴 거리감을 조성하여 민족의 이산(離散)을 효과적으로 표현하는 ‘조

15
Article|3 citations·2013
전후희곡에 나타난 전쟁미망인의 ‘자기갱신’ 문제 - 임희재 희곡 연구
백두산

이 연구는 임희재의 희곡 <꽃잎을 먹고 사는 기관차>에 나타난 전쟁미망인의 형상화와 그 의미를 살피고, 전후희곡에 등장하는 전쟁미망인과 상이군인 형상화의 특이성을 규명하려는 시론(試論)이다. 이 작품은 전쟁미망인을 다룬 여타의 희곡과 달리 ‘실종된 남편이 살아 돌아온다면’이라는 가정을 서스펜스의 축으로 삼는다. 이 과정에서 전쟁미망인을 둘러싼 사회적 담론과 극텍스트가 구현하는 영자의 서사는 극 안에서 분열하는 양상을 보인다. 50년대 전쟁미망인에 대한 사회적 담론은 극텍스트에서 신문광고와 박형래의 유서(遺書)를 통해 제시된다. <꽃잎을 먹고 사는 기관차>의 특이성은 바로 이러한 공적 영역의 담론들에 대하여 전쟁미망인 영자가 대응하고 있다는 것이다. 극텍스트에서 김영자는 질문에 대하여 답변하며, ‘증언’의 방식으로 과거를 진술한다. 증언을 통한 개인의 과거와 신문광고, 유서 텍스트의 정보는 서로 경쟁관계에 놓인다. 나아가 김영자는 옷차림의 변신, 육체의 발견과 패션의 모방, 재가의 욕

Research Areas

Radiology, Nuclear Medicine and ImagingOncologyImmunologyElectrical and Electronic EngineeringInformation SystemsImmunology and Allergy

Dive deeper into Doo-San Baek's research on Nubint

Open this lab's papers in the app to read with AI, summarize, and cite in your writing.